Insulin Glargine U-300 Injection, Solution
Product Images NDC 0955-3900

Product Visual Gallery

This gallery contains 51 technical images submitted to the FDA as part of the official labeling for Insulin Glargine U-300 (NDC 0955-3900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Insulin Glargine 01)

This is a graph that shows the Glucose Infusion Rate (GIR) in mg/(kg*min) over time in hours after a subcutaneous injection. The values are presented on a table and a graph but no additional information is available.*

FDA Label Image

Image (Insulin Glargine 02)

This text provides a list of body parts: Upper arms, stomach and thighs.*

FDA Label Image

Image (Insulin Glargine 03)

This appears to be a product manual for a device used for administering doses of insulin. The device features a dose window, dose pointer, dose selector, insulin scale, and an injection button. There is also a pen cap and rubber seal. The manual indicates that the plunger will not be visible until after several doses have been administered.*

FDA Label Image

Image (Insulin Glargine 04)

FDA Label Image

Image (Insulin Glargine 05)

FDA Label Image

Image (Insulin Glargine 06)

FDA Label Image

Image (Insulin Glargine 07)

FDA Label Image

Image (Insulin Glargine 08)

FDA Label Image

Image (Insulin Glargine 09)

FDA Label Image

Image (Insulin Glargine 10)

FDA Label Image

Image (Insulin Glargine 11)

FDA Label Image

Image (Insulin Glargine 12)

FDA Label Image

Image (Insulin Glargine 13)

FDA Label Image

Image (Insulin Glargine 14)

FDA Label Image

Image (Insulin Glargine 15)

FDA Label Image

Image (Insulin Glargine 16)

FDA Label Image

Image (Insulin Glargine 17)

FDA Label Image

Image (Insulin Glargine 18)

FDA Label Image

Image (Insulin Glargine 19)

FDA Label Image

Image (Insulin Glargine 20)

FDA Label Image

Image (Insulin Glargine 21)

FDA Label Image

Image (Insulin Glargine 22)

FDA Label Image

Image (Insulin Glargine 23)

FDA Label Image

Image (Insulin Glargine 24)

FDA Label Image

Image (Insulin Glargine 25)

FDA Label Image

Image (Insulin Glargine 26)

This is a list of body parts that includes the upper arms, stomach and thighs.*

FDA Label Image

Image (Insulin Glargine 27)

The text describes the parts of a cartridge holder used for injecting insulin. It includes a dose window and pointer, dose selector, injection button, pen cap, rubber seal, insulin scale, and insulin name. The plunger is not visible until after some doses have been administered.*

FDA Label Image

Image (Insulin Glargine 28)

FDA Label Image

Image (Insulin Glargine 29)

FDA Label Image

Image (Insulin Glargine 30)

FDA Label Image

Image (Insulin Glargine 31)

This appears to be a dosage strength specification for a medication, likely intended for subcutaneous injection. The unit "units/mL" is commonly used to measure the concentration of medications such as insulin. Without further context or information about the specific medication, it is difficult to provide more details.*

FDA Label Image

Image (Insulin Glargine 32)

FDA Label Image

Image (Insulin Glargine 33)

FDA Label Image

Image (Insulin Glargine 34)

FDA Label Image

Image (Insulin Glargine 35)

FDA Label Image

Image (Insulin Glargine 36)

FDA Label Image

Image (Insulin Glargine 37)

FDA Label Image

Image (Insulin Glargine 38)

FDA Label Image

Image (Insulin Glargine 39)

FDA Label Image

Image (Insulin Glargine 40)

FDA Label Image

Image (Insulin Glargine 41)

FDA Label Image

Image (Insulin Glargine 42)

FDA Label Image

Image (Insulin Glargine 43)

FDA Label Image

Image (Insulin Glargine 44)

FDA Label Image

Image (Insulin Glargine 45)

FDA Label Image

Image (Insulin Glargine 46)

FDA Label Image

Image (Insulin Glargine 47)

FDA Label Image

Image (Insulin Glargine 48)

FDA Label Image

Image (Insulin Glargine 49)

FDA Label Image

Principal Display Panel (1.5 mL Pen Carton)

This is a description of insulin glargine U-300 SoloStar, which is a disposable insulin delivery device intended for subcutaneous use only. The solution is to be used only for single patient use and should not be removed with a syringe. It is advised to mix it gently before use and only use it if clear and colorless with no visible particles. The prefilled pens are to be used within 56 days after opening and needles are not included. The product is manufactured by Winthrop. GTIN number 0030955390035 is also provided.*

FDA Label Image

Principal Display Panel (3 mL Pen Carton)

This is a product description and instructions for use of a disposable insulin delivery device called Insulin glargine U-300 Max SoloStar®. The product is Rx only and is only for single patient use. Two 3mL pre-filled pens are dispensed in a sealed carton and needles are not included. The solution should be clear and colorless with no visible particles and should be used within 28 days of opening. The product should not be mixed with other insulins and always use a new needle for administration. The text also includes some product identification numbers.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.